Dr Abhishek Katakwar discusses Mounjaro: benefits, potential side effects, and the importance of personalised management for successful treatment. Get the facts about Mounjaro: potential side effects, how to minimise them, and what to discuss with your doctor. Make informed decisions about your health.
Mounjaro (tirzepatide) has emerged as a promising medication for managing type 2 diabetes and, in some cases, obesity. Its innovative dual-action mechanism, targeting both GIP and GLP-1 receptors, has shown significant benefits for many individuals. However, like any medication, Mounjaro can come with potential concerns and side effects. This blog post aims to address these concerns and offer strategies to help you navigate your Mounjaro journey.
What is Mounjaro and How Does It Work?
Mounjaro is an injectable medication approved for the treatment of type 2 diabetes. It works by mimicking the effects of two naturally occurring hormones:
By targeting both GIP and GLP-1 receptors, Mounjaro can effectively lower blood sugar levels and promote weight loss in some individuals. Clinical trials have demonstrated its efficacy in improving glycemic control in patients with type 2 diabetes (Cosentino F, et al., 2021).
Common Side Effects and How to Manage Them
While Mounjaro can be highly effective, it's important to be aware of potential side effects:
Gastrointestinal Issues: Nausea, vomiting, diarrhea, constipation, and abdominal pain are among the most common side effects.
Decreased Appetite: Mounjaro can suppress appetite, which can lead to weight loss, but also potential nutrient deficiencies if not managed carefully.
Injection Site Reactions: Some people may experience redness, swelling, or itching at the injection site.
Hypoglycemia (Low Blood Sugar): When used with other diabetes medications (like insulin or sulfonylureas), Mounjaro can increase the risk of hypoglycemia.
Gallbladder Problems: GLP-1 receptor agonists, a class of medications to which Mounjaro belongs, have been associated with an increased risk of gallbladder problems, such as gallstones (Diabetes UK, 2023).
Pancreatitis: Although rare, pancreatitis (inflammation of the pancreas) has been reported with GLP-1 receptor agonists.
Emerging Concerns and Controversies
As Mounjaro gains wider use, some concerns have emerged in social media and online forums:
Important Considerations and Precautions
Dr. Abhishek Katakwar's Perspective
Dr. Abhishek Katakwar emphasizes the importance of a balanced approach to managing type 2 diabetes and obesity. "Mounjaro can be a valuable tool when used appropriately and under the guidance of a healthcare professional," says Dr. Katakwar. "It's crucial to address potential side effects proactively and focus on sustainable lifestyle changes for long-term success."
References
Connect with Dr. Katakwar and AIG Hospitals:
Disclaimer: This blog post is for informational purposes only and does not constitute medical advice. Always consult with your doctor or other qualified healthcare provider for any questions you may have regarding a medical condition or treatment.
© 2025 Dr. Abhishek Katakwar. All Rights Reserved.